Plant-based vaccines as a global vaccination approach: Current perspectives

Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases: An Integrated View

Volumn , Issue , 2014, Pages 265-280

  Govea Alonso, Dania O ^a   Rybicki, Edward ^b   Rosales Mendoza, Sergio ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Biofarming; Global immunization; Low cost vaccines; Marketing; Perspectives; Plant production; Research goals

Indexed keywords

EID: 84929866619     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-0850-9_13     Document Type: Chapter

References (67)

1. Alvarez ML, Done SC, Cardineau GA (2013) Reverse vaccination and treatment of type 1 diabetes using plant-produced autoantigens and antiinflammatory cytokines. J Clin Cell Immunol S 2:007
2. Bachmann MF, Jennings GT (2011) Therapeutic vaccines for chronic diseases: successes and technical challenges. Philos Trans R Soc Lond B Biol Sci 366:2815-2822
3. Berinstein NL (2002) Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review. J Clin Oncol 20:2197-2207
4. Castro-Díaz N, Salaun B, Perret R, Sierro S, Romero JF, Fernández JA, Rubio-Moraga A, Romero P (2012) Saponins from the Spanish saffron Crocus sativus are efficient adjuvants for proteinbased vaccines. Vaccine 30:388-397
5. Center for Biologics Evaluation and Research (US), Center for Drug Evaluation and Research (US), Center for Food Safety and Applied Nutrition (US), Center for Devices and Radiological Health (US), Center for Veterinary Medicine (US), Center for Veterinary Biologics (US), & United States (2002) Guidance for industry: drugs, biologics and medical devices derived from bioengineered plants for use in humans and animals. U. S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville
6. Davies HM (2010) Review article: commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnol J 8:845-861
7. Franconi R, Demurtas OC, Massa S (2010) Plant-derived vaccines and other therapeutics produced in contained systems. Expert Rev Vaccines 9:877-892
8. Fraunhofer (2011) Clinical tests for medicines made from genetically modified plants. http://www.ime.fraunhofer.de/en/presse-medien/clinical-tests.html. Accessed 21 April 2014.
9. Fujkuyama Y, Tokuhara D, Kataoka K, Gilbert RS, McGhee JR, Yuki Y, Kiyono H, Fujihashi K (2012) Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 11:367-379
10. Garg NK, Mangal S, Khambete H, Tyagi RK (2010) Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers. Recent Pat Drug Deliv Formul 4:114-128
11. Gebril A, Alsaadi M, Acevedo R, Mullen AB, Ferro VA (2012) Optimizing efficacy of mucosal vaccines. Expert Rev Vaccines 11:1139-1155
12. Goldstein DA, Thomas JA (2004) Biopharmaceuticals derived from genetically modified plants. QJM 97:705-716
13. Gouiaa S, Khoudi H, Leidi EO, Pardo JM, Masmoudi K (2012) Expression of wheat Na (+)/H (+) antiporter TNHXS1 and H (+)-pyrophosphatase TVP1 genes in tobacco from a bicistronic transcriptional unit improves salt tolerance. Plant Mol Biol 79:137-155
14. Ha SH, Liang YS, Jung H, Ahn MJ, Suh SC, Kweon SJ, Kim DH, Kim YM, Kim JK (2010) Application of two bicistronic systems involving 2A and IRES sequences to the biosynthesis of carotenoids in rice endosperm. Plant Biotechnol J 8:928-938
15. Halpin C, Cooke SE, Barakate A, Amrani AE, Ryan MD (1999) Self-processing 2A-polyproteins-a system for co-ordinate expression of multiple protein in transgenic plants. Plant J 17:453-459
16. Hammarstrom S (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9:67-81
17. Hammond RW, Nemchinov LG (2009) Plant production of veterinary vaccines and therapeutics. Curr Top Microbiol Immunol 332:79-102
18. Hayden CA, Streatfield SJ, Lamphear BJ, Fake GM, Keener TK, Walker JH, Clements JD, Turner DD, Tizard IR, Howard JA (2012) Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen. Vaccine 30:2937-2942
19. Hefferon K (2013) Plant-derived pharmaceuticals for the developing world. Biotechnol J. doi:10.1002/biot.201300162
20. Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, Vézina LP (2010) Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS ONE 5:e15559
21. Langridge W, Dénes B, Fodor I (2010) Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases. Curr Opin Investig Drugs 11:919-928
22. Levine OS, Bloom DE, Cherian T, de Quadros C, Sow S, Wecker J, Duclos P, Greenwood B (2011) The future of immunisation policy, implementation, and financing. Lancet 378:439-448
23. Marillonnet S, Giritch A, Gils M, Kandzia R, Klimyuk V, Gleba Y (2004) In planta engineering of viral RNA replicons: Efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proc Natl Acad Sci USA 101:6852-6857
24. Mascola JR (2002) Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1. Vaccine 20:1922-1925
25. McCormick AA, Kumagai MH, Hanley K, Turpen TH, Hakim I, Grill LK, Tusé D, Levy S, Levy R (1999) Rapid production of specific vaccines for lymphoma by expression of the tumorderived single-chain Fv epitopes in tobacco plants. Proc Natl Acad Sci USA 96:703-708
26. Medicago Inc (2013) Product pipeline. http://www.medicago.com/English/Products/product-pipeline/default.aspx. Accessed 15 Oct. 2013
27. Melnik S, Stoger E (2013) Green factories for biopharmaceuticals. Curr Med Chem 20:1038-1046
28. Mestecky J, Nguyen H, Czerkinsky C, Kiyono H (2008) Oral immunization: an update. Curr Opin Gastroenterol 24:713-719
29. Michoux F, Ahmad N, McCarthy J, Nixon PJ (2011) Contained and high-level production of recombinant protein in plant chloroplasts using a temporary immersion bioreactor. Plant Biotechnol J 9:575-584
30. Mosolits S, Nilsson B, Mellstedt H (2005) Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials. Expert Rev Vaccines 4:329-350
31. Nojima J, Ishii-Katsuno R, Futai E, Sasagawa N, Watanabe Y, Yoshida T, Ishiura S (2011) Production of anti-amyloid β antibodies in mice fed rice expressing amyloid β. Biosci Biotechnol Biochem 75:396-400
32. Obembe OO, Popoola JO, Leelavathi S, Reddy SV (2011) Advances in plant molecular farming. Biotechnol Adv 29:210-222
33. Otsuki N, Dang NH, Kumagai E, Kondo A, Iwata S, Morimoto C (2010) Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects. J Ethnopharmacol 127:760-767
34. Pelosi A, Shepherd R, Guzman GD, Hamill JD, Meeusen E, Sanson G, Walmsley AM (2011) The release and induced immune responses of a plant-made and delivered antigen in the mouse gut. Curr Drug Deliv 8:612-621
35. Pelosi A, Piedrafita D, De Guzman G, Shepherd R, Hamill JD, Meeusen E, Walmsley AM (2012) The effect of plant tissue and vaccine formulation on the oral immunogenicity of a model plantmade antigen in sheep. PLoS ONE 7:e52907
36. Penney CA, Thomas DR, Deen SS, Walmsley AM (2011) Plant-made vaccines in support of the millennium development goals. Plant Cell Rep 30:789-798
37. Pharma-Planta (2011) First approval for production of an anti-HIV monoclonal antibody in plants. http://www.pharma-planta.net/images/file/Pharma-Planta-Press-release-July2011.pdf Accessed 15 Oct. 2013
38. Pniewski T, Kapusta J, Bociąg P, Wojciechowicz J, Kostrzak A, Gdula M, Fedorowicz-Strońska O, Wójcik P Otta H, Samardakiewicz S, Wolko B, Plucienniczak A (2011) Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation. J Appl Genet 52:125-136
39. Potterat O, Hamburger M (2008) Drug discovery and development with plant-derived compounds. Prog Drug Res 65:47-118
40. Protalix (2011) Our Lead Product Candidate, taliglucerase alfa (prGCD). http://www.protalix. com/glucocerebrosidase.html. Accessed 15 Oct. 2013
41. Rader R (2009) FDA biopharmaceutical product approvals and trends: significantly more approvals were granted in 2009. http://www.biopharma.com/approvals-2009.html. Accessed 15 Oct. 2013
42. Robert JS, Kirk DD (2006) Ethics, biotechnology, and global health: the development of vaccines in transgenic plants. Am J Bioeth 6:W29-W41
43. Mendoza S, Govea-Alonso DO, Monreal-Escalante E, Fragoso G, Sciutto (2012a) Developing plant-based vaccines against neglected tropical diseases: where are we? Vaccine 31:40-8
44. Rosales-Mendoza S (2012b) Can a plant-based vaccine treat hypertension? Med Hypotheses 79:555-559
45. Rosales-Mendoza S, Soria-Guerra RE, Moreno-Fierros L, Govea-Alonso DO, Herrera-Díaz A, Korban SS, Alpuche-Solís AG (2011) Immunogenicity of nuclear-encoded LTB: ST fusion protein from Escherichia coli expressed in tobacco plants. Plant Cell Rep 30:1145-1152
46. Rosales-Mendoza S, Orellana-Escobedo L, Romero-Maldonado A, Decker E, Reski R (2013) The potential of Physcomitrella patens as a platform for the production of plant-based vaccines. Expert Rev Vaccines 13(2):203-212
47. Rybicki EP (2009) Plant-produced vaccines: promise and reality. Drug Discov Today 14:16-24
48. Rybicki EP (2010) Plant-made vaccines for humans and animals. Plant Biotechnol J 8:620-637
49. Rybicki EP, Hitzeroth II, Meyers A, X Dus Santos MJ, Wigdorovitz A (2013) Developing country applications of molecular farming: case studies in South Africa and Argentina. Curr Pharm Des 19:5612-5621
50. Salazar-González JA, Rosales-Mendoza S (2013) A perspective for atherosclerosis vaccination: is there a place for plant-based vaccines? Vaccine 31:1364-1369
51. Samanci A, Yi Q, Fagerberg J, Strigård K, Smith G, Rudén U, Wahren B, Mellstedt H (1998) Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen. Cancer Immunol Immunother 47:131-142
52. Schepetkin IA, Quinn MT (2006) Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int Immunopharmacol 6:317-133
53. Scotti N, Rybicki EP (2013) Virus-like particles produced in plants as potential vaccines. Expert Rev Vaccines 12(2):211-224
54. Skarjinskaia M, Ruby K, Araujo A, Taylor K, Gopalasamy-Raju V, Musiychuk K, Chichester JA, Palmer GA, de la Rosa P, Mett V, Ugulava N, Streatfield SJ, Yusibov V (2013) Hairy roots as a vaccine production and delivery system. Adv Biochem Eng Biotechnol. doi:10.1007/102013-184
55. Streatfield SJ (2005) Regulatory issues for plant-made pharmaceuticals and vaccines. Expert Rev Vaccines 4:591-601
56. Streatfield SJ, Howard JA (2003) Plant production systems for vaccines. Expert Rev Vaccines 2:763-775
57. Tiwari S, Verma PC, Singh PK, Tuli R (2009) Plants as bioreactors for the production of vaccine antigens. Biotechnol Adv 27:449-467
58. van der Laan JW, Minor P, Mahoney R, Arntzen C, Shin J, Wood D, WHO Informal Consultation Group (2006) WHO informal consultation on scientific basis for regulatory evaluation of candidate human vaccines from plants, Geneva, Switzerland, 24-25 January 2005. Vaccine 24:4271-4278
59. Veazey RS, Shattock RJ, Pope M, Kirijan JC, Jones J, Hu Q, Ketas T, Marx PA, Klasse PJ, Burton DR, Moore JP (2003) Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med 9:343-346
60. Walmsley AM, Arntzen CJ (2000) Plants for delivery of edible vaccines. Curr Opin Biotechnol 11:126-129
61. Walmsley AM, Arntzen CJ (2003) Plant cell factories and mucosal vaccines. Curr Opin Biotechnol 14:145-150
62. WHO (2009) Global health risks: mortality and burden of disease attributable to selected major risks. World Health Organization
63. WHO (2010) First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. World Health Organization. WHO/HTM/NTD/2010.1
64. WHO (2011) Global status report on noncommunicable diseases 2010. World Health Organization
65. Wong G (2009) Biotech scientists bank on big pharma's biologics push. Nat Biotechnol 27:293-295
66. Yusibov V, Rabindran S (2008) Recent progress in the development of plant derived vaccines. Expert Rev Vaccines 7:1173-1183
67. Yusibov V, Streatfield SJ, Kushnir N (2011) Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccin 7:313-321.